- Home
- MPC vs EW Comparison
MPC vs EW Comparison
Compare MPC & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MPC | EW |
|---|---|---|
| Founded | 1887 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Industrial Specialties |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.2B | 45.5B |
| IPO Year | 2011 | 2000 |
Fundamental Metrics
Financial Performance| Metric | MPC | EW |
|---|---|---|
| Price | $185.60 | $83.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 21 |
| Target Price | ★ $202.92 | $95.16 |
| AVG Volume (30 Days) | 2.0M | ★ 3.3M |
| Earning Date | 11-04-2025 | 10-30-2025 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 9.24 | 2.33 |
| Revenue | ★ $133,581,000,000.00 | $5,883,800,000.00 |
| Revenue This Year | N/A | $14.26 |
| Revenue Next Year | N/A | $9.77 |
| P/E Ratio | ★ $20.10 | $35.66 |
| Revenue Growth | N/A | ★ 10.60 |
| 52 Week Low | $115.10 | $65.94 |
| 52 Week High | $202.30 | $87.89 |
Technical Indicators
Market Signals| Indicator | MPC | EW |
|---|---|---|
| Relative Strength Index (RSI) | 40.67 | 46.91 |
| Support Level | $186.92 | $83.08 |
| Resistance Level | $192.42 | $84.60 |
| Average True Range (ATR) | 4.24 | 1.55 |
| MACD | -0.83 | -0.51 |
| Stochastic Oscillator | 7.55 | 2.37 |
Price Performance
Historical ComparisonAbout MPC Marathon Petroleum Corporation
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 3.0 million barrels per day. Its Dickinson, North Dakota, facility produces 184 million gallons a year of renewable diesel. Its Martinez, California, facility has the ability to produce 730 million gallons a year of renewable diesel. The firm also owns and operates midstream assets primarily through its listed master limited partnership, MPLX.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.